Invention Grant
US09254266B2 Inhibiting surface enhanced crystallization of amorphous pharmaceuticals with ultrathin coatings 有权
用超薄涂层抑制无定形药物的表面增强结晶

Inhibiting surface enhanced crystallization of amorphous pharmaceuticals with ultrathin coatings
Abstract:
The present invention provides surface-stabilized amorphous pharmaceuticals comprising an amorphous pharmaceutical substrate coated with a biocompatible immobilizing material. Amorphous pharmaceutical substrates that are prone to surface enhanced crystallization benefit from the present coatings. The coated amorphous pharmaceuticals of the present invention maintain their amorphous state and, therefore, their solubility over extended periods of time, relative to uncoated pharmaceuticals.
Information query
Patent Agency Ranking
0/0